APVO - Aptevo Therapeutics EPS misses by $0.66 beats on revenue March, 31 2021 08:40 AM Aptevo Therapeutics Inc. Aptevo Therapeutics (APVO): FY GAAP EPS of -$5.23 misses by $0.66.Revenue of $4.31M beats by $0.63M.Press Release For further details see: Aptevo Therapeutics EPS misses by $0.66, beats on revenue